XML 72 R33.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Components of (Loss) Income before (Provision) Benefit for Income Taxes
The components of loss before benefit for income taxes from continuing operations are as follows:

Year Ended December 31,

2019
 
2018
 
2017
United States
$
(139,682
)
 
$
(133,165
)
 
$
(121,507
)
Foreign
(4,912
)
 
4,558

 
(1,185
)
Total
$
(144,594
)
 
$
(128,607
)
 
$
(122,692
)

Provision (Benefit) for Income Taxes
The benefit for income taxes from continuing operations consist of the following:
 
Year Ended December 31,
 
2019
 
2018
 
2017
Current:

 

 

Federal
$
(6,584
)
 
$
(1,663
)
 
$
(15,412
)
State
(1,166
)
 
(269
)
 
(1,298
)
Foreign
11

 

 
6


$
(7,739
)
 
$
(1,932
)
 
$
(16,704
)
Deferred:

 

 

Federal
(781
)
 
12

 
(5,256
)
State
(688
)
 
19

 
19


(1,469
)
 
31

 
(5,237
)
Total income tax benefit
$
(9,208
)
 
$
(1,901
)
 
$
(21,941
)

Income Tax Provision (Benefit) Differs from Computed Using Federal Statutory Rate Applied to Income before Taxes
The income tax benefit differs from that computed using the applicable federal statutory rate, as applied to our income before taxes in each year as follows:
 
Year Ended December 31,

2019
 
2018
 
2017
Tax provision computed at the federal statutory rate
$
(30,365
)
 
$
(26,854
)
 
$
(42,614
)
State tax, net of federal benefit
(4,126
)
 
(5,077
)
 
(2,207
)
Research and development expense tax credits
(2,526
)
 
(4,884
)
 
(1,176
)
Change in uncertain tax benefit reserve

 

 
(561
)
Change in tax credit carryforwards
81

 
(3,056
)
 
386

Officers compensation
1,506

 
600

 
(9,292
)
Stock based compensation
(230
)
 
(12,610
)
 
(2,734
)
Permanent items and other
267

 
(116
)
 
1,450

Tax differential on foreign earnings
(31
)
 
(32
)
 
33

Change in tax rate
1,126

 
(1,329
)
 
37,768

Refundable alternative minimum tax credit

 

 
(1,336
)
Change in prior year deferred taxes
1,170

 
6,595

 
(1,218
)
Valuation allowance
23,920

 
44,862

 
(440
)
Income tax benefit
$
(9,208
)
 
$
(1,901
)
 
$
(21,941
)

Components of Company's Deferred Tax Assets
Significant components of our deferred tax assets and liabilities as of December 31, 2019 and 2018 are presented below. A valuation allowance has been recognized to offset the net deferred tax assets as realization of such deferred tax assets did not meet our “more-likely-than-not” assessment threshold, as required under GAAP.
 
December 31,
 
2019
 
2018
Deferred tax assets:

 

Net operating loss carry forwards
$
118,163

 
$
103,582

Research and development expense tax credits
22,724

 
21,618

Stock based compensation
4,385

 
5,057

Lease obligation
919



Development costs
704

 
3,938

Returns and allowances
1,069

 
1,976

Other, net
11,861

 
7,185

Total deferred tax assets before valuation allowance
159,825

 
143,356

Valuation allowance
(152,966
)
 
(131,042
)
Total deferred tax assets
6,859

 
12,314

Deferred tax liabilities, net:

 

Unrealized gains
(5,607
)
 
(9,387
)
Depreciation and amortization differences
(389
)
 
(4,396
)
Right-of-use asset
(863
)
 

Net deferred tax liabilities
$

 
$
(1,469
)

Summary of Unrecognized Tax Benefits
The following tabular reconciliation summarizes the activity related to our unrecognized tax benefits:
 
Year Ended December 31,
 
2019
 
2018
 
2017
Balance at beginning of year
$
3,248

 
$
2,715

 
$
3,271

Adjustments related to prior year tax positions
(392
)
 
(551
)
 
(39
)
Increases related to current year tax positions
692

 
1,084

 
374

Decreases due to expiration of tax statutes
(75
)
 

 
(891
)
Balance at end of year
$
3,473

 
$
3,248

 
$
2,715